AIMS/HYPOTHESIS: The risk of developing diabetes is greater for women with previous gestational diabetes mellitus (GDM). In the general population, plasma lipidomic analysis can identify individuals at risk of developing type 2 diabetes. The aim of this study was to determine whether circulating lipid levels 12 weeks following a GDM pregnancy were associated with an increased risk of developing type 2 diabetes. METHODS: Plasma lipid profiles containing >300 lipids were measured in 104 normal glucose-tolerant women 12 weeks following an index GDM pregnancy using electrospray-ionisation tandem mass spectrometry. Women were assessed for 10 years for development of overt type 2 diabetes. RESULTS: Among the 104 women with previous GDM, 21 (20%) developed diabetes during the median follow-up period of 8.5 years. Three lipid species, the cholesteryl ester species CE 20:4, the alkenylphosphatidylethanolamine species PE(P-36:2) and the phosphatidylserine species PS 38:4, were independently and positively associated with the development of type 2 diabetes. In a clinical model of prediction of type 2 diabetes that included age, BMI, and levels of pregnancy fasting glucose, postnatal fasting glucose, triacylglycerol and total cholesterol, the addition of these three lipid species resulted in an improvement in the net reclassification index of 22.3%. CONCLUSIONS/ INTERPRETATION: The lipid species CE 20:4, PE(P-36:2) and PS 38:4 were significant risk factors for the development of type 2 diabetes in women with a previous history of GDM. This report is the first to use plasma lipidomic analysis to identify individual lipids as potential biomarkers for the prediction of type 2 diabetes in women with a history of GDM.
AIMS/HYPOTHESIS: The risk of developing diabetes is greater for women with previous gestational diabetes mellitus (GDM). In the general population, plasma lipidomic analysis can identify individuals at risk of developing type 2 diabetes. The aim of this study was to determine whether circulating lipid levels 12 weeks following a GDM pregnancy were associated with an increased risk of developing type 2 diabetes. METHODS: Plasma lipid profiles containing >300 lipids were measured in 104 normal glucose-tolerant women 12 weeks following an index GDM pregnancy using electrospray-ionisation tandem mass spectrometry. Women were assessed for 10 years for development of overt type 2 diabetes. RESULTS: Among the 104 women with previous GDM, 21 (20%) developed diabetes during the median follow-up period of 8.5 years. Three lipid species, the cholesteryl ester species CE 20:4, the alkenylphosphatidylethanolamine species PE(P-36:2) and the phosphatidylserine species PS 38:4, were independently and positively associated with the development of type 2 diabetes. In a clinical model of prediction of type 2 diabetes that included age, BMI, and levels of pregnancy fasting glucose, postnatal fasting glucose, triacylglycerol and total cholesterol, the addition of these three lipid species resulted in an improvement in the net reclassification index of 22.3%. CONCLUSIONS/ INTERPRETATION: The lipid species CE 20:4, PE(P-36:2) and PS 38:4 were significant risk factors for the development of type 2 diabetes in women with a previous history of GDM. This report is the first to use plasma lipidomic analysis to identify individual lipids as potential biomarkers for the prediction of type 2 diabetes in women with a history of GDM.
Authors: Ebru Boslem; Gemma MacIntosh; Amanda M Preston; Clarissa Bartley; Anna K Busch; Maria Fuller; D Ross Laybutt; Peter J Meikle; Trevor J Biden Journal: Biochem J Date: 2011-04-01 Impact factor: 3.857
Authors: V D F de Mello; M Lankinen; U Schwab; M Kolehmainen; S Lehto; T Seppänen-Laakso; M Oresic; L Pulkkinen; M Uusitupa; A T Erkkilä Journal: Diabetologia Date: 2009-08-11 Impact factor: 10.122
Authors: Peter J Meikle; Gerard Wong; Despina Tsorotes; Christopher K Barlow; Jacquelyn M Weir; Michael J Christopher; Gemma L MacIntosh; Benjamin Goudey; Linda Stern; Adam Kowalczyk; Izhak Haviv; Anthony J White; Anthony M Dart; Stephen J Duffy; Garry L Jennings; Bronwyn A Kingwell Journal: Arterioscler Thromb Vasc Biol Date: 2011-11 Impact factor: 8.311
Authors: Jacquelyn M Weir; Gerard Wong; Christopher K Barlow; Melissa A Greeve; Adam Kowalczyk; Laura Almasy; Anthony G Comuzzie; Michael C Mahaney; Jeremy B M Jowett; Jonathan Shaw; Joanne E Curran; John Blangero; Peter J Meikle Journal: J Lipid Res Date: 2013-07-18 Impact factor: 5.922
Authors: E Bonora; G Targher; M Alberiche; G Formentini; F Calcaterra; S Lombardi; F Marini; M Poli; L Zenari; A Raffaelli; S Perbellini; M B Zenere; F Saggiani; R C Bonadonna; M Muggeo Journal: Diabet Med Date: 2002-07 Impact factor: 4.359
Authors: James Boon; Andrew J Hoy; Romana Stark; Russell D Brown; Ruth C Meex; Darren C Henstridge; Simon Schenk; Peter J Meikle; Jeffrey F Horowitz; Bronwyn A Kingwell; Clinton R Bruce; Matthew J Watt Journal: Diabetes Date: 2012-11-08 Impact factor: 9.461
Authors: Lucy Liaw; Igor Prudovsky; Robert A Koza; Rea V Anunciado-Koza; Matthew E Siviski; Volkhard Lindner; Robert E Friesel; Clifford J Rosen; Paul R S Baker; Brigitte Simons; Calvin P H Vary Journal: J Cell Biochem Date: 2016-03-16 Impact factor: 4.429
Authors: Pooja Subedi; Helena Palma-Gudiel; Oliver Fiehn; Lyle G Best; Elisa T Lee; Barbara V Howard; Jinying Zhao Journal: Geroscience Date: 2022-08-11 Impact factor: 7.581
Authors: Saifur R Khan; Haneesha Mohan; Ying Liu; Battsetseg Batchuluun; Himaben Gohil; Dana Al Rijjal; Yousef Manialawy; Brian J Cox; Erica P Gunderson; Michael B Wheeler Journal: Diabetologia Date: 2019-01-15 Impact factor: 10.122
Authors: Mugdha V Joglekar; Wilson K M Wong; Fahmida K Ema; Harry M Georgiou; Alexis Shub; Anandwardhan A Hardikar; Martha Lappas Journal: Diabetologia Date: 2021-03-23 Impact factor: 10.122
Authors: Yu Liu; Alan Kuang; James R Bain; Michael J Muehlbauer; Olga R Ilkayeva; Lynn P Lowe; Boyd E Metzger; Christopher B Newgard; Denise M Scholtens; William L Lowe Journal: J Clin Endocrinol Metab Date: 2021-10-21 Impact factor: 6.134